Scott Mendel, President & CEO at GenMark Diagnostics, Inc. (GNMK), sold 50,000 shares at $14.54 ($727K) on 2021-01-19, disclosed to the SEC on 2021-01-21.
Open-market sale of $727k GNMK by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GNMK | SELL | 2021-01-25 | $1.8M | — | Filing → |
| GNMK | SELL | 2020-11-25 | $137K | — | Filing → |
| GNMK | SELL | 2020-11-20 | $110K | — | Filing → |